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Objecti f du projet  
Etudier par l’imagerie FRET le récepteur membranaire β2-adrénergique 
exprimé dans des cellules vivantes (HEK 293) au vu de déterminer son 
auto-association. Les récepteurs sont marqués par réaction enzymatique 
avec deux fluorophores nommés Cy3 et Cy5 à différents rapports. 
Méthodes | Expériences | Résultats  
A partir du FRET apparent mesuré, le degré d’oligomérisation du 
récepteur β2-adrénergique est de 4.1 ± 0.6 avec une distance de 64.8 ± 
1.8 Å entre les récepteurs. Le récepteur β2-adrénergique n’est pas sous 
forme de dimère. 
Dans le domaine d’expression de récepteurs analysé, le FRET apparent 
n’est pas dépendant du niveau d’expression du récepteur. La déplétion 
du cholestérol de la membrane cellulaire ne montre pas de décroissance 
du signal du FRET apparent. Ceci ne permet dès lors pas de prouver la 
présence de microdomaines à sa surface. 
Il y a donc une interaction protéine-protéine qui fait que le récepteur β2-
adrénergique est présent sous forme d’oligomère de structure 
tétramérique dans la membrane cellulaire au niveau d’expression étudié. 
 
Objectives 
Auto-association of the β2-adrenergic receptor expressed in life cells 
(HEK 293) was studied by FRET imaging. Therefore, receptors are 
labelled by enzymatic reaction with two fluorophores, namely Cy3 and 
Cy5, in different ratios. 
Methods / Experiences / Results  
From the apparent FRET measured, the oligomerization degree of β2-
adrenergic receptors is 4.1 ± 0.6, with a distance of 64.8 ± 1.8 Å between 
receptors. β2-adrenergic receptor does not appear as a dimeric structure 
in the plasma membrane. 
From the expression levels that were analyzed, apparent FRET did not 
appear to be dependent on the expression level. Depletion of membrane 
plasma cholesterol does not show a decrease of apparent FRET signal. 
The presence of microdomains in the plasma membrane is not 
demonstrated. 
A protein-protein interaction is proposed that make β2-adrenergic 
receptors appear as oligomer with a tetrameric structure in the plasma 
membrane for analyzed expression level. 
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1. Abbrevations 
 
 
7TM  Seven transmembrane 
A  FRET Acceptor 
AcRe  Acceptors Receptors  
ACP  Acyl carrier protein 
BRET  Bioluminescence Resonance Energy Transfert 
CoA  Coenzyme A 
Cy3  Cyanine fluorescent dye  
Cy5  Cyanine fluorescent dye  
D  FRET Donor 
DA  Ratio donor/acceptor 
DMEM  Dulbecco’s modified Eagle medium 
DNA  Desoxyribo nucleid acid 
E  FRET efficiency  
Eapp,se  FRET efficiency for sensitized acceptor emission  
FBS  Fetal bovine serum 
FR  FRET ratio 
FRET  Fluorescence or Förster Resonance Energy Transfert 
GPCR  G protein-coupled receptor 
HEK  Human embryonic kidney  
MBCD  Methyl-β-cyclodextrin 
n  Number of units in an oligomer  
PBS Phosphate-buffered saline 
r Intermolecular distance 
XD Donor mole fraction 
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2. Introduction 
 
 
The First target in this diploma thesis was an introduction to cell biology and the basic 
manipulation of live cells, like cell culture maintenance, transfection or labelling. 
The Second objective was the comprehension of Förster Resonance Energy Transfer 
(FRET) imaging in confocal microscopy and its application to a G-protein-coupled receptor 
(GPCR), the β2-adrenergic receptor, to determine the degree of oligomerization. 
 
2.1. Förster Resonance Energy Transfer 
 
Förster resonance energy transfer (FRET) is an electrodynamic phenomenon that can be 
explained using classical physics. FRET occurs between a donor molecule (D) in the excited 
state by a laser and an acceptor molecule (A) in the ground state. Donor emit at shorter 
wavelength that overlap with the absorption spectrum of the acceptor. Energy transfer leads 
to the appearance of a photon and is the result of long-range dipole-dipole interactions 
between donor and acceptor. [Lakowicz, 2006] 
 
FRET is determined by illuminating the donor and measuring emission from the acceptor. By 
using two different spectral variants of cyanine fluorescent dyes as the fluorophores, one can 
monitor the interaction of any two fluorophores and, when applied to the β2-adrenegic 
receptor, the oligomerization of this receptor. [Alberts et al, 2002] 
 
The explanation of this energy transfer is given by the Jablonski diagram (Figure 2.1). The 
diagram shows that the donor is excited (kex) by a photon into higher vibrational levels of the 
first singlet state S1 of the donor D*. Following vibrational relaxation to the lowest vibrational 
state of D*, the excitation energy is lost spontaneously by one of the following conversions: 
(kisc) intersystem crossing to the triplet state, (kf) radiative decay to the ground state, or the 
most important constant: (kT) long-range resonance dipole energy transfer to an acceptor 
molecule close to the excited donor molecule. [Wieb Van Der Meer, 1994]  
 
 
 
Figure 2.1: Jablonski diagram showing the transitions between donor and acceptor 
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Förster [Förster, 1948] has deduced an equation from the transfer signal to measure the 
distance between donor and acceptor (Equ. 2.1).  
 
 
           [Equ. 2.1] 
 
Where:  
 
E: efficiency of energy transfer 
r: intermolecular distance 
R0: distance between donor-acceptor pair 
 
The consequence of the sixth power of  in Equ. 2.1 is that an increase in the distance 
between acceptor and donor from r = R0 to r = 2R0 leads to a decrease in E from 50% to 
1.5%.  
 
 
 
Figure 2.2: dependence of FRET efficiency to distance r [Meyer, 2005] 
 
Another equation to describe the efficiency of energy transfer for a fixed distance between 
donor and acceptor is Equ. 2.2. 
 
 
[Equ. 2.2] 
 
Where:  
 
E: efficiency of energy transfer 
FAD: fluorescence intensity of the acceptor in the presence of the donor 
FA: fluorescence intensity of the acceptor only 
εA: molar extinction coefficient of the acceptor 
εD: molar extinction coefficient of the donor 
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In practice, Equ. 2.2 must be corrected for biological systems, where the distance r is not 
constant (Equ. 2.3). 
 
 
 
[Equ. 2.3] 
Where: 
 
Xa: fraction of acceptor in complex with the donor 
 
Finally, the FR (FRET ratio) can be calculated with a procedure on the IGOR Pro software 
(Version 6.02, Wavemetrics Inc.) developed by Meyer [Meyer, 2005] and adapted by J-B 
Perez, (Equ. 2.4). 
 
 
 
[Equ. 2.4] 
 
Where : 
 
Ff : signal from a donor-acceptor sample using FRET channel 
Df : signal from a donor-acceptor sample using donor channel 
Af : signal from a donor-acceptor sample using acceptor channel 
S1, S4 : cross-talks 
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2.2. Fluorophores 
 
A fluorophore is a functional group in a molecule that absorbs energy of a specific 
wavelength and re-emit energy at a higher wavelength. The amount and wavelength of the 
emitted energy depend on both the fluorophore and the chemical environment. [Lakowicz, 
2006] 
Different pairs of fluorophores can be used for measuring the FRET signal, like CFP/YFP, 
CF/TR or Alexa488/Cy3. [Pawley, 2006] 
For this diploma thesis, the two fluorophores used were Cy3 and Cy5. They are water-
soluble fluorescent dyes of the cyanine family. Cy3 is used as a donor and Cy5 as acceptor. 
[Pawley, 2006] 
 
 
 
 
Figure 2.3: Excitation (blue line) and emission (red line) spectrum for Cy3 and Cy5 [Held, 2005] 
 
Two key conditions required for FRET are: (i) spectral overlap between the emission of the 
donor molecule and the excitation of the acceptor and, (ii) close proximity between donor and 
acceptor (less than 100 Å). [Milligan, 2004] 
 
For Cy3/Cy5, the two conditions are fulfilled. The spectral overlap is present as presented in 
Figure 2.3, and the distance between the donor and acceptor (R0) is 50 Å. [Lakowicz, 2006] 
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2.3. Biological and pharmaceutical applications 
 
FRET is a powerful technique for studying molecular interactions inside living cells with a 
very spatial (Ångstrom) and temporal (nanosecond) resolution, distance range, sensitivity, 
and a broad range of biological applications. [Sekar and Periasamy, 2003] 
 
One application in biology is the onset and termination of Ca2+ signalling in cells, like the 
cytoplasm, nucleus, or endoplasmic reticulum, which can be observed by measuring of 
donor/acceptor intensities. [Truong et al., 2001] 
 
FRET is used in molecular biology sees too an application of FRET technique  for membrane 
fusion assays. In the lipid-mixing assay, membranes labelled with donor and acceptor lipid 
probes are mixed with unlabelled membranes. The FRET signal starts to decrease when the 
fusion between labelled and unlabelled membranes begins. [Sekar and Periasamy, 2003] 
 
In bioanalysis, FRET immunoassays is an alternative to ELISA or others techniques using 
antigens and antibodies. [Miller, 2005] 
 
Finally, the last application mentioned concerns carbohydrates. The FRET technique has 
permitted to define the flexibility and conformation of N-linked glycans. [Rice, 2001] 
 
In this diploma thesis, we are interested by G-protein-coupled receptors. distance between 
two receptors is measured by using the FRET technique. 
 
2.4. G-protein-coupled receptors 
 
G-protein-coupled receptors (GPCRs) represent one of the largest and most diverse groups 
of proteins encoded by the genome in mammals. 
Nearly 800 different human genes encode receptors for various extracellular ligands, 
including hormones, neurotransmitters and sensory stimuli. Moreover, these receptors are 
the targets of 30% of all pharmaceuticals on the market. [Oldham and Hamm, 2008] 
All GPCRs have seven transmembrane-spanning (7TM) α-helices, an extracellular N 
terminus, an intracellular C terminus and three interhelical loops on each side of the 
membrane. 
Based on phylogenetic analysis, human GPCRs can be classified into five main families of 
receptors: rhodopsin, secretin, glutamate adhesion and frizzled-taste-2. [Oldham and Hamm, 
2008] 
Family A (rhodopsin) is by far the largest group, and includes the receptors for light 
(rhodopsin), adrenaline (adrenergic receptors) and, most other 7TM receptor types, including 
the olfactory receptor subgroup. [ Pierce et al., 2002] 
 
For this diploma thesis, the receptor of interest is the β2-adrenergic receptor. 
It is part of a family of rhodopsin receptors which is a target for catecholamines, especially 
noradrenaline and adrenaline. 
In 2007, the β2-adrenergic receptor has been crystallized in a monomeric state and the 
structure was determined by high-brilliance microcrystallography. [Rasmussen et al., 2007] 
However, it is unclear if this monomeric state represents a true physiological state or if the 
oligomeric state has been disrupted by purification or crystallization. [Dalrymple et al., 2008] 
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The β2-adrenergic receptor can be activated with an agonist molecule like showed in Figure 
2.4. 
 
 
 
Figure 2.4 : In the absence of agonist, the β2-adrenergic receptor are in the low –affinity strate. After 
agonist binding, a transient high-affinity complex of agonist, activated receptor and G protein is 
formed. GDP released frome G protein and is replaced by GTP. This leads to dissociation of the G-
protein complex into a-subunits ans bg dimers, wich both activte several effectors. [Pierce et al., 2002] 
 
 
This particular receptor (β2-adrenergic receptor) is one of the most studied GPCRs with 
respect to agonists and antagonists [Breit et al., 2004].  
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3. Materials and Methods 
3.1. Materials 
 
Biological and chemical materials used : 
 
- ACP-β2-adrenergic DNA gift from Karen L. Martinez, Nano-Science center, 
Copenhagen 
- CoA-Cy3, CoA-Cy5, AcpS gift from Ruud Hovius, Institute of Chemical Sciences and 
Engineering, Lausanne 
- DMEM/F12 + GlutaMax, Gibco 31331, Invitrogen  
- Effectene®, Qiagen, Cat N° 301425 
- Fetal Bovine Serum, Sigma F7524 
- HEK 293T/17, ATCC CRL-11268, LGC 
- G418 sulfate, Gibco 11811023, Invitrogen 
- Isoproterenol, Sigma I5627 
- Methyl-β-cyclodextrin, Sigma C4555 
- MgCl2·6H2O > 99.0%, Fluka 63065  
- PBS 10x pH 7.2, Gibco 70013, Invitrogen  
- Trypsin-EDTA solution (1x), Sigma T3924 
- Water, NANOpur, Barnstead 
 
Materials used : 
 
- 8-well plate borosilicate,Nunc  
- Centrifuge, Eppendorf 5415 D 
- Centrifuge, Eppendorf 5810 R 
- Confocal microscope LSM 510, Zeiss 
- Glass coverslips 0.17 mm thick X 25 mm diameter, Assistant 
- Glass coverslips 24 X 50 mm, Menzel-Gläser 
- Incubator Hera cell 150, Hereaeus 
- Microscope Axiovert 25, Zeiss 
- Tissue culture flasks 25 cm2, TPP 90025 
 
 
3.2. Methods 
 
3.2.1 Cell culture maintenance 
 
 
HEK 293 
Adherent HEK 293 were grown in DMEM/F12 supplemented with 10% FBS and maintained 
at 37 °C. Cells were sub-cultivated twice a week at ratios between 1:10 and 1:20. 
 
 
Stable HEK 293 
Stable HEK 293 cell lines with ACP-β2-adrenergic receptor were maintained by selection with 
200 µg/ml G418 in DMEM/F12 supplemented with 10% FBS. 
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Cell culture in 8-well 
 
 
HEK 293 
For the preparation of 8-well plates, 50 µl of cells in DMEM/F12 and 10% FBS were added in 
each well. 50 µl medium DMEM/F12 are supplemented with 10% FBS and finally 100 µl of 
DMEM/F12 was added. The final concentration of FBS was 5% and the concentration of 
cells was 1*105/ml.  
8-well plates were kept at 37 °C. Cells were transfected after 24h. [Meyer, 2005] 
 
 
Stable HEK 293 
For the preparation of 8-well plates, 100 µl of cells in DMEM/F12 with 200 µg/ml G418 and 
10% FBS were added in each well, and finally 100 µl of DMEM/F12 was added. The final 
concentration of FBS was 5% and the concentration of cells was 1*105/ml.  
8-well plates were kept at 37 °C. Analysis by confocal microscopy was made after 48 h. 
 
3.2.2 Transfection 
 
Two different methods for transfection were used. The objective was to have a fast method 
with a good yield, at a minimum cost. 
 
 
3.2.2.1 Calcium-phosphate method 
Transfection by using the calcium-phosphate method for 8 well plates: [Jordan et al., 1996] 
 
4.5 µl plasmid DNA (0.1 µg/µl) in 200 µl phosphate buffer (140mM NaCl, 1.4mM Na2HPO4, 
50mM HEPES, pH 7) were added with 200 µl 250mM calcium buffer. Cells were transfected 
after exactly 1 minute by adding 50 µl were tranvased in each well and there after incubated 
at 37 °C. 4 h later, the medium was changed to 200 µl DMEM/F12 supplemented with 5% 
FBS at 37 °C. Analysis by confocal microscopy was made 48 h later. 
 
 
3.2.2.2 Effectene® method 
Transfection by using Effectene® in reagent for 8 well plates based on Qiagen method. 
3.2 µl DNA (0.1 µg/µl) were added in 160 µl Buffer EC. 2.56 µl Enhancer were added. The 
solution was vortexed for a few seconds. After 5 minutes, 3.2 µl Effectene® were added. 
Finally, 10 minutes later, 20 µl were transferred in each well then incubated at 37 °C. 
Analysis by confocal microscopy was made 48 h later. 
 
 
After comparing the two methods, a choice was made in favour of Effectene® transfection. 
This method is more repeatable, faster and easier than calcium-phosphate transfection.  
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3.2.3 ACP labelling 
 
Before labelling, cells were washed once with 100 µl 1X PBS. Labelling was performed in 1X 
PBS with 10mM MgCl2, 1μM AcpS and 5 μM CoA substrate. Total volume was 52 µl. For 
double labelling with Cy3 and Cy5, the substrates, CoA-Cy3 and CoA-Cy5, were mixed 
beforehand at desired ratios to a total concentration of 5 μM. The labelling was performed at 
ambient temperature for 40 minutes. After incubation the cells were washed three times with 
1X PBS and the cells were maintained with 200 µl 1X PBS. [Meyer, 2005]. 
 
3.2.4 Internalization assay 
 
The cells were labelled as described in point 3.2.3. For induction of receptor endocytosis, 
cells were stimulated for 30 min with 1 µM isoproterenol at 37°C. [Breit and al., 2004] 
3.2.5 Cholesterol extraction 
 
After labelling of cells with Cy3 and Cy5, cholesterol was extracted with 2% methyl-β-
cyclodextrin (MBCD) for 45 minutes at room temperature. 
 
3.2.6 Confocal microscope 
 
Laser-scanning confocal micrographs were recorded on a LSM 510 microscope (Zeiss) with 
a 63X (1.2 NA, W Korr, Zeiss) objective by using 543 nm and 633 nm HeNe lasers. Detection 
and distinction of fluorescence signals was achieved by appropriate filter sets using a 
multitracking mode (See Table 3.1). 
 
Table 3.1 Multitracking parameters 
 
Channel Excitation Line 
Dichroic Mirror 
(HFT) 
Beam Splitter 
(NFT) 
Emission 
Filter 
Donor 543 nm UV/488/543/633 635 Vis BP 560-615 
Acceptor 633 nm UV/488/543/633 635 Vis LP 650 
FRET 543 nm UV/488/543/633 635 Vis LP 650 
 
The donor and FRET images were taken at same time, because they are excited at the 
same wavelength. laser Intensity at 543 nm was between 126 to 700 nW (70%) and at 633 
nm between 84 to 767 nW (10%). 
For experiments, laser power was adjusted according to the level of receptor expression at 
the cell surface. Channel intensity was generally between 1’000 and 3’000 (units?) on 
plasma membrane. 
Another important parameter in confocal microscopy is pinhole aperture size. In our 
experiments, it was 2.96 Airy units. This parameter defined the axial resolution (z-axis). 
[Pawley, 2006] 
For more information about confocal microscopy methodology and practices, refer to the 
work of Bruno Meyer. [ Meyer, 2005] 
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4. Results 
 
4.1. Cross-talk calculations 
 
To calculate the FRET ratio exactly, cross-talk is a very important parameter. Cross-talk 
depends on many parameters of signal acquisition, like laser power, settings and intensity. 
 
First assay was a direct measure. a solution of Cy3 (or Cy5) in PBS was measured with the 3 
channels. The problem was that donor and acceptor channel had a high intensity and that 
the FRET channel had a low intensity. Cross-talks are changing according to intensity. This 
way to calculate cross-talks S1 and S4 was not one. 
 
The second method to try was using a solution of Cy3 (or Cy5) in PBS and with a change of 
laser power.  
 
For the first step, a solution of Cy3 30 µM in PBS (or Cy5 14.8 µM) was added on a coverslip 
until the intensity of the histogram on the Zeiss software was a Gaussian. Then different 
images were made with different powers on all intensity ranges. 
The second step was to make a dilution for that FRET channel and donor (or acceptor) 
channel could be measured with the same solution. This step enables one to know the 
dilution factors between the different assays. 
The Final step was the same as the first step, but the solution was more diluted for the donor 
(or acceptor) channel.  
 
 
 
Figure 4.1: Histogram for acceptor channel with Cy5 
 
 12 
 
 
Figure 4.2: Histogram for FRET channel with Cy5 
 
 
Based on histograms (Figure 4.1 and Figure 4.2), a graph was made for calibration of 
intensity as a function of laser power. The laser power response was linear with intensity for 
both acceptor channel and donor channel (Figure 4.3 and Figure 4.4). 
 
 
 
Figure 4.3: Intensity as a function of laser power for donor channel with Cy3. Slope 32.6 ± 0.4 and 
 R2 = 0.9990 
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Figure 4.4: Intensity as a function of laser power for acceptor channel with Cy5. Slope 349 ± 2 and 
 R2 = 0.9990 
 
 
However, no linearity has been observed in the FRET channel (Figure 4.5). 
 
 
 
Figure 4.5: Intensity in function of laser power for FRET channel with Cy3 
 
 
To solve this problem, a double calibration curve was made in function of intensity. 
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Figure 4.6: Intensity as a function of laser power for FRET channel with application of two calibration 
curves with Cy3. High curve: slope 43.7 ± 0.4 and R2 = 0.996, 
 low curve: slope 61 ± 3, y-intercept 508 ± 56 and R2 = 0.997 
 
Using two calibration curves (Figure 4.6), it is possible to obtain an all intensities range for 
the FRET channel. For donor and acceptor, these problems were not present. 
 
From the different calibration curves, we can calculate cross-talks S1 (Equ. 4.1 ) and S4 
(Equ. 4.2). 
 
 and  
 
[Equ. 4.1 and Equ. 4.2] 
 
 
Error propagation calculation gives a maximal relative error of 11.9% for S1 and 2.4% for S4. 
[Skoog et al., 2007] 
 
From S1 and S4, one can calculate the FR mean relative error with the following parameters 
(Table 4.1). 
 
Table 4.1 Parameters to the calculation of FR mean relative error 
 
 
Value Δ value 
Acceptor channel [Intensity] 1000 50 
FRET channel [Intensity] 1000 90 
Donor channel [Intensity] 1000 50 
S1 0.126 0.002 
S4 0.400 0.004 
 
 
The propagation error in FR for the last parameters (Table 4.1), FR was 2.19 and mean error 
was 0.11. In percentages, the mean relative error was 5.2%.  
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Still, the main FR error comes from intensity on the plasma membrane. In fact, depending on 
the threshold applied, results can change from 10 to 20%. In our experiment, threshold was 
increased to keep the highest plasma membrane intensity until the FR histogram looks like a 
normal distribution (see Figure 4.11). 
 
For FR calculation, Equ. 2.4 was modified as a function of FRET channel intensity. If 
intensity was under the crossing between the high curve and low curve, Equ. 4.3 was 
applied. 
 
 
 
[Equ. 4.3] 
Where:  
 
S1A1: slope for high curve in FRET channel with Cy3 
S1A2: slope for low curve in FRET channel with Cy3 
S1B2: intercept for low curve in FRET channel with Cy3 
S4A1: slope for high curve in FRET channel with Cy5 
S4A2: slope for low curve in FRET channel with Cy5 
S4B2: intercept for low curve in FRET channel with Cy5 
 
4.2. Labelling of β2-adrenergic receptors 
 
ACP-β2-adrenergic receptors were double labelled with Cy3 and Cy5.  
Only extracellular receptors were labelled. Donor is shown by the left image, centre is 
acceptor and FRET right. The colours are artificial. Detectors give only an intensity. 
 
 
 
 
Figure 4.7: labelling of β2-adrenergic receptors with Cy3 (left), Cy5 (centre). FRET signal is right. 
Donor ratio was DA 0.67/0.33. Scale bar: 5 µm. 
 
Like demonstrated by Bruno Meyer [Meyer, 2005], for a receptor fused at its N-terminus with 
ACP and double labelled with CoA-Cy3 and CoA-Cy5, the Donor/Acceptor ratios in solution 
for labelling should correspond exactly to the real DA ratios obtained on the cells. 
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4.3. Internalization assay 
 
A test to observe internalization of β2-adrenergic receptors was effected according method 
3.2.4. Endocytosis was initiated by isoproterenol. This assay permits to know if the labelling 
is specific for β2-adrenergic receptor.  
 
 
 
Figure 4.8: FRET canal image: cell in contact with 1 µM isoproterenol labelled with XD 0.65 
 
We can see that with isoproterenol (Figure 4.8), FRET signal is on the plasma membrane 
and inside the cell. This phenomenon is explained by endocytosis of the β2-adrenergic 
receptor. This experiment confirms that β2-adrenergic receptors are internalized in presence 
of isoproterenol and it is an indication for the proper functioning of our receptor. 
 
4.4. Photobleaching 
 
Photobleaching was recorded for the highest laser power used for measuring the FR. A 
degradation of donor or acceptor will give a mistaken value for FR. 
Scan speed was set to 2.56 µs (same parameters as for all images). 543 nm and 633 nm 
lasers were used for illuminating of, respectively, Cy3 (Figure 4.9) and Cy5 (Figure 4.10). 
 
 
 
Figure 4.9: Measure of intensity for Cy3 as a function of number of scans at 543 nm and 70% laser 
power 
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Figure 4.10: Measure of intensity for Cy5 as a function of number of scans at 633 nm and 10% laser 
power 
 
 
After 30 scans at 543 nm, intensity decreases from 100 % to 98.3 %. At 633 nm and after 50 
scans, intensity decreases from 100 % to 97.1 %. 
Intensities for Cy3 and Cy5 did not decrease significantly with the number of scans for lasers 
power of 70% at 543 nm and 10% at 633 nm.  
There is thus no photobleaching for the two highest lasers power used. 
 
4.5. Oligomerization of β2-adrenergic receptor 
 
FR calculations have been performed using IGOR software. Methodology for the treatment of 
results was explained by Bruno Meyer. [Meyer, 2005] 
 
Figure 4.11 shows FR on plasma membrane of two cells (left) and the FR value (right). 
 
 
Figure. 4.11: FR image (left) and FR histogram (right) value for two cells with DA ratio 0.65/0.35.  
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To obtain FRET efficiency for sensitized acceptor emission (Eapp,se) from FR, Equ. 4.4 has 
been proposed. [Erickson et al., 2001] 
 
 
[Equ. 4.4] 
 
Oligomerization degree can be calculated with Eapp,se and XD. From different theories [Adair 
and Engelman, 1994; Veatch and Stryer, 1977], Meyer has developed a model to calculate 
FRET efficiency (E) and number of units in an oligomer (n) with Equ. 4.5. 
 
 
 
[Equ. 4.5] 
 
To apply this model, receptors must be completely labelled. This hypothesis is admitted to be 
fulfilled in our experiment. 
 
Calculation of receptor density is not indicate with a concentration but calculated only with 
acceptors receptors labelled. 
Like acceptor is proportional to XD [Meyer, 2005], acceptors receptors (AcRe) is calculated 
by Equ. 4.6. 
 
 
[Equ. 4.6] 
 
The ratio between acceptor intensity at the plasma membrane of each cell is given by IGOR 
software, and divided by the laser power in percentage, multiplied with the donor mole 
fraction. 
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The first hypothesis is that β2-adrenergic receptors are expressed as a dimer, with n = 2. 
[Angers et al. (2002); Mercier et al. (2004)]  
Number of acceptors receptors expressed at the cell surface is between 50 to 300. 
 
 
Figure 4.12: Eapp,se between β2-adrenergic receptors at different donor mole fraction with n set to 2 
between 50 to 300 acceptors receptors 
 
With β2-adrenergic receptors, n= 2 (Figure 4.12) in Equ 4.5, the true Efficiency, E= 0.39 ± 
0.02. Each point is a mean (± SD) of 4 to 12 cells.  
One can see that with XD < 0.5, all points are under the linear curve, and with XD > 0.65, 
points are above the linear curve. 
There is clearly a deviation of the line and order 2 (n=2) does not correspond to an accurate 
fit. 
 
The second case is with n not restricted. 
 
 
 
Figure 4.13: Eapp,se between β2-adrenergic receptors at different donor mole fraction for AcRe between 
50 to 300 acceptors receptors 
 
After application of Equ 4.5 on Figure 4.13, the true Efficiency E= 0.18 ± 0.02 , and the 
oligomerization degree n= 4.1 ± 0.5. Each point is a mean (± SD) of 4 to 12 cells.  
Thus the β2-adrenergic receptor is present in the plasma membrane as an oligomer, probably 
as a tetramer.  
 20 
 
With a restricted domain of acceptor receptors, range 150-200 AcRe, the oligomerization 
degree does not change and stays around 4.  
 
 
 
Figure 4.14: Eapp,se between β2-adrenergic receptor at different donor mole fractions for AcRe between 
150 and 200 
 
After application of Equ 4.5 on Figure 4.14, the true Efficiency E= 0.17 ± 0.02 , and the 
oligomerization degree n= 4.1 ± 0.8. Each point is a mean (± SD) of 1 to 9 cells. 
 
 
 
Assay was performed with a stable HEK 293 ACP-β2-adrenergic receptor. The domain 
Range of AcRe is 130-450. 
 
 
 
Figure 4.15: Eapp,se between β2-adrenergic receptor at different donor mole fraction for stable HEK293 
 
After application of Equ 4.5 on Figure 4.15, the true Efficiency E= 0.14 ± 0.02 , and the 
oligomerization degree n= 4.1 ± 0.7. Each point is a mean (± SD) of 7 to 11 cells. 
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 We can also obtain the intermolecular distance (r) by Equ. 4.7. 
 
 
[Equ. 4.7] 
 
The distance between Cy3-Cy5 is 50 Å (R0) [Kenworthy and Edidin, 1998], with E= 0.18 ± 
0.02. In cases with a range between 50 and 300 AcRe, the calculated intermolecular 
distance is 64.74 ± 1.74 Å.  
 
4.6. Dependence of FRET ratio on receptors density 
 
To determine dependence of FRET to the density of receptors, all points with a DA ratio of 
0.5/0.5 have been used, from experiments of three different days. Number of cells were N= 
24. 
 
 
 
Figure 4.16: Variation of FR with the number of acceptors receptors for DA ratio 0.5/0.5 
 
Figure 4.16 was fitted with a linear function. The intercept is 1.919 ± 0.159 and the slope 
0.00047 ± 0.00105. Slope can be considered zero within the margin of error.  
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Same Figure is made for a DA ratio of 0.85/0.15 for three different days and N= 18: 
 
 
 
Figure 4.17: Variation of FR with the number of acceptors receptors for DA ratio 0.85/0.15 
 
Figure 4.17 was fitted with a linear function. The intercept is 4.269 ± 0.618 and the slope is 
0.00029 ± 0.00472.  
 
Consequently, for the expression cells obtained, there is no dependence between FR and 
the number of receptors on a range of 4.  
 
4.7. Cholesterol depletion 
 
For cholesterol depletion, method 3.2.5 was used. Cells were labelled with a donor mole 
fraction of XD= 0.63. 
 
Two samples of cells are analyzed. One with 2% MBCD and another without MBCD like 
control (Figure 4.18). 
 
 
Figure. 4.18: Variation of FR by cholesterol extraction for a donor mole fraction of XD=0.63 (± SD) 
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A T-Test is done to determine if segregation is present between control cells and cells 
treated with 2% MBCD.  
 
 
Table 4.2: Cholesterol depletion results 
 
 
Sample 
 
control 2% MBCD 
cells number 11 7 
average [FR] 2.55 2.7 
standard deviation [FR] 0.14 0.33 
S 0.231 
t  1.314 
 
For cholesterol depletion results, t obtained is 1.314. (Table 4.2) 
 
For a degree of freedom of 16 and a 95% confidence interval, t limit is 2.120 [Fisher and 
Yates, 1963].  
 
Because the value for t is lower than t limit, the two samples are identical. There is no 
segregation, thus no influence of MBCD substance on FR for β2-adrenergic receptor. 
 
4.8. Maximal FRET ratio 
 
Maximal FRET ratio is dependent on the type of fluorophores. The following value is the ideal 
case depending of molar extinction: 
 
maximal FR (DA 0.5/0.5) is Equ. 4.8. 
 
 
[Equ. 4.8] 
 
For the Cy3-Cy5 pair, the ratio   at 543 nm is 0.11 [Meyer, 2005] 
 
Thus, maximal FR for a labelling with DA 0.5/0.5 is 10.1. 
 
In our experiment, for a labelling with Cy3/Cy5 0.5/0.5, we obtain the following result: 
 
FR= 1.99 ± 0.08 (0.20, 95%, 24) 
 
The value obtained indicates that the experimental FR is under the maximal FR and thus 
there is no aberration for FR value. 
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5. Discussion 
 
5.1. FRET techniques parameters 
 
Calculation of cross-talks S1 and S4 was the first problem. The FR strongly depends on 
these parameters. A bad correction of these terms and the FR would be completely false.  
The relative error obtained for FR is of 5.2%. This error is an analytic error. But, like 
mentioned in point 4.1, the main error is due to the intensity of fluorophores on the plasma 
membrane. FR varies depends on the position in plasma membrane. To obtain a Gaussian 
curve, only the center of plasma membrane has been kept with an intensity more or less 
constant.  
 
A comparison with cross-talks of Bruno Meyer [Meyer, 2005] can be made and the result is 
that values are more or less similar for the same fluorophores and parameters. Based on 
these observations, cross-talks determined using Equ. 4.3 can be accepted. When intensities 
in membrane plasma for FRET channel is similar, the FR histogram has a normal distribution 
(Figure 4.11). 
5.2. Oligomerization 
 
This work is the first application of FRET technique to determine oligomerization degree of 
β2-adrenergic receptor. However, many experiments have already applied FRET technique 
to other 7TM receptors, for example Neuropeptide Y1 [Dinger et al., 2003], neurokinin-1 
receptor [Meyer, 2005] or α1b-adrenergic receptors. [Stanasila et al., 2003] 
 
The measured degree of oligomerization of β2-adrenergic receptors does not correspond to 
BRET experiments which have demonstrated that β2-adrenergic receptor is a homo-dimer 
[Mercier et al., 2002; Angers et al., 2000]. 
Based on results shown in figure 4.12, degree of oligomerization is not the value n = 2. This 
hypothesis shows the impossibility to have β2-adrenergic receptor like a homo-dimer. 
 
Our results obtained with application of Equ. 4.5 for Figures 4.13 to 4.15 indicate that β2-
adrenergic receptor is an oligomer, but with a tetrameric structure and not a dimeric 
structure.  
 
Another group dismisses the hypothesis that β2-adrenergic receptor can form homodimers. 
They has been determined that β2-adrenergic receptor is a monomer which form oligomer 
structure. [James et al., 2006] 
 
Finally, it has been suggested that for rhodopsin receptors, lipid-mediated protein-protein 
interactions provide an additional mechanism that governs the association process and does 
tend to oligomerize, and that the membrane environment affects the extent of 
oligomerization. An equivalent model can be suggested for β2-adrenergic receptor. [Periole et 
al., 2007] 
 
The estimated diameter for a GPCR is 40-50 Å. [Palczewski et al., 2000; Mercier et al., 2002; 
James et al., 2006] 
The calculated distance is 64.8 ± 1.8 Å. Thus, this distance is larger than obtained from 
estimations in the literature. The upper distance is another argument for the hypothesis that 
the β2-adrenergic receptor is not a dimer with strong interactions, but protein-protein 
interactions between 4 units. 
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Our results bring a new lighting on β2-adrenergic receptor. Using FRET, we demonstrate that 
this receptor is under form of oligomer in plasma membrane. It does not a dimer but more 
specifically an oligomer with 4 units.  
5.3. Dependence of FRET ratio on receptor density 
 
For GPCRs, different experiments were done on many receptors to observe the FR variation 
with the density of receptors and results are different between different receptors. 
Meyer have demonstrated that for NK1R (neurokinin-1 receptor) MBCD has decreasing 
effect on FR, suggesting a model where NK1Rs are localized in lipid microdomains. [Meyer, 
2005] 
For others GPCRs, results are different. Between adenosine A2A receptors [Canals et al., 
2004] or A2A and D2Rs [Canals et al., 2003], BRET signals are no affected by the variation of 
receptors density. 
 
This work shows for β2-adrenergic receptor that for a variation of receptors of a factor 4, 
there is no dependence of FRET ratio on the density of receptors. Two different DA ratios 
give the same result (Figure 4.16 and Figure 4.17). 
The degree of Oligomerization is the same for a large domain (50-300 AcRe, Figure 4.13), a 
reduced domain (150-200 AcRe, Figure 4.14) and the stable HEK 293 (130-450 AcRe, 
Figure 4.15). FR is not dependent to receptors for the studied domain.  
These results show that degree of oligomerization of the β2-adrenergic receptor does not 
change with the number of receptors on membrane plasma. In the analyzed domain, the β2-
adrenergic receptor forms always an oligomer with a tetrameric structure. 
Domain with more receptors can not be analyzed because with a strongly concentration of 
receptors, cells comes spherical and it is impossible to measure FR.  
 
Two other research groups have studied the β2-adrenergic receptor by BRET technique. 
For the first group, The BRET signal is dependent on cell expression. The BRET efficiency 
increases with the increase of receptors. Those authors think that BRET showed randomly 
interacting proteins. [James et al., 2006]. This result indicates that the β2-adrenergic receptor 
is not a dimer but an oligomer. 
In opposite, another group observes that between 1.4 to 26 pmol/mg β2-adrenergic receptor 
expression level, BRET signal does not increase and is stable. In this domain, the β2-
adrenergic receptor concentration does not influence on the BRET signal. After this domain, 
we can see that the BRET level increase with the receptor level. [Mercier et al., 2002] 
These results show that for a domain (1.4 to 26 pmol/mg), β2-adrenergic receptor is a dimer. 
With more than 47 pmol/mg, the BRET increase from random collision between evenly 
dispersed donor and acceptor molecule. [Kenworthy and Edidin, 1998] 
 
It is difficult to compare the two different groups, because in the first case there is no 
indication about the expression level range.  
Another difficulty is the minimal level concentration (1.4 pmol/mg) is 18 fold over reported for 
human heart tissues (~0.080 pmol/mg) [Bristow et al., 1986]. It has not been demonstrated 
that β2-adrenergic receptor is present as a dimer at physiological expression level. 
 
In this work, our results show no dependence of FRET ratio on the density of receptors 
without knowing exactly what our expression level is.  
We have at least a factor 4 between low and high expression without leading to any variation 
in the FR.  
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5.4. Cholesterol depletion 
 
Contrary to NK1-receptor which shows a decreasing of FR with cholesterol depletion [Meyer, 
2005], same experiment on β2-adrenergic receptors shows no influence on the FR. This 
result was obtained after a T-test (Table. 4.2). 
There are no microdomains in which β2-adrenergic receptors can be concentrated with the 
cholesterol depletion method. 
The result obtained without variation of FR for β2-adrenergic receptors is similar than another 
group showed for two different GPCRs, Adenosine A2A and dopamine D2. [Canals et al., 
2003; Canals et al., 2004] 
 
Nevertheless, we should extent the result of cholesterol depletion to the influence of lipids in 
bilayers. 
A new approach by simulations of model bilayers shows that localized adaptation of the 
membrane bilayer is due to the presence of receptors. These experiments were made with 
rhodopsin monomers. It shows that the type of lipids in the bilayer can influence FRET 
efficiency. This local membrane deformation appears to be a key factor defining the rate, 
extent and orientational preference of protein-protein association. [Periole et al., 2007] 
 
With the result of cholesterol depletion, an assay on one day for two different samples does 
not show the presence of microdomains with the β2-adrenergic receptor. More assays will 
must be effected to confirm this result.  
 
6. Conclusion and Outlook 
 
The β2-adrenergic receptor was studied by FRET imaging in HEK 293 life cells. Results 
obtained shows that β2-adrenergic receptors are present in the plasma membrane in the form 
of oligomers, with an interaction protein-protein of degree four (tetrameric structure). There is 
no dependence between expression level of receptors and FRET ratio for expression levels 
analyzed. Finally, cholesterol depletion indicates that there is no influence on the FR.  
 
The next step for the β2-adrenergic receptor, to complete results for this work, would be the 
estimation of receptor surface density on cells with stable HEK 293 by lipid vesicles 
preparation to compare our results with literature.  
 
FRET experiment will must be done with a physiological expression level of β2-adrenergic 
receptor in life cells and a temperature of 37°C for same condition as in human body. Only 
these conditions will can give the exactly structure of β2-adrenergic receptors for human 
tissues with exactitude.  
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9. Annexe 
 
[1] ACP-β2AR vector information 
 
 
ACPI13?AR
Responsible
Date
: Nladia Cherouati
z 26.09.06
l_
Location
Box name
Position
Location
Box name
Position
DIYA stock
-80 freezer, rack I
DNA stock
A7 (3.1 pe/Wl)
Glycerol Stock
-80 freezer, rack I
DNA Glycerol stock
I
Name
Supplier
Size
Organism
Selection marker
More info
pcDIYA3. l*-_
5428 bps
E. coli strains
ampicillin resistance
For more vector info look in the file (file name)
Plasmid map
hil.sas tQ22.10:t*
*s 1i]?& ! ?52
cDi\A3.1 (+l-,
5{2tll5127 }tp
Description
Position
Insert
: signal seq5FIT3-ACP-B2AR
: between Nhel and BamHI in MCS
Expressed region
Description
# f{ucleotides
# Amino acids
Molecular weight
ACP-B2AR
1497 bps
497 aa
5591lg/mol)
Nucleotide sequence of expressed region:
ATGCGGCTCTGCATCCCGCAGGTGCTGTTGGCCTTGTTCCTTTCCATGCTG
ACAGGGC CGGGAGAAGGCAGCCGGAGGAGGGCCAC CCAGATCGATTACG
TAATGAGCACTATCGAAG AACGCGTTAAG AA AATTATCGGCGAACAGCTG
GGCGTTAAGCAGGAAGAAGTTAC CAACAATGCTTCTTTC GTTGAAGAC CT
GGGCGCGGATTCTCTTGACACCGTTGAGCTGGTAATGGCTCTGGAAGAAG
AGTTTGATACTGAGATTCC GGACGAAGAAGCTGAG AudA.ATCACCA C C GTT
CAGGCTGCCATTGATTACATCAACGGCCACCAGGCGAAGCTTATGGGGCA
ACCCGGGAACGGCAGCGCCTTCTTGCTGGCACCCAATAGAAGCCATGCGC
CGGACCACGACGTCACGCAGCAAAGGGAC GAGGTGTGGGTGGTGGGCAT
GGGCATCGTCATGTCTCTCATCGTCCTGGCCATCGTGTTTGGCAATGTGCT
GGTCATCACAGCCATTGCCAAGTTCGAGC GTCTGCAGACGGTCACCAACT
ACTTCATCACTTCACTGGCCTGTGCTGATCTGGTCATGGGCCTGGCAGTGG
TGCCCTTTGGGGCCGCCCATATTCTTAT6 A"q,MI6TGGACTTTTGGCAACT
TCTGGTGC GAGTTTTGGACTTCCATTGATGTGCTGTGCGTCACGGCCAGCA
TTGAGACCCTGTGCGTGATCGCAGTGGATCGCTACTTTGCCATTACTTCAC
CTTTCAAGTACCAGAGCCTGCTGACCAAGAATAAGGCCCGGGTGATCATT
CTGATGGTGTGGATTGTGTCAGGCCTTACCTCCTTCTTGCCCATTCAGATG
CACTGGTACCGGGCCACCCACCAGGAAGCCATCAACTGCTATGCCAATGA
GACCTGCTGTGACTTCTTCACGAACCAAGC CTATGCCATTGCCTCTTCCAT
CGTGTCCTTCTAC GTTCCCCTGGTGATCATGGTCTTCGTCTACTCCAGGGT
CTTTCAGGAGGCCAAAAGGCAGCTCCAGAAGATTGACAAATCTGAGGGCC
GCTTCCATGTCCAGAACCTTAGCCAGGTGGAGCAGGATGGGCGGACGGGG
CATGGACTCCGCAGATCTTCCAAGTTCTGCTTGAAGGAGCACAAAGCCCT
CAAGACGTTAGGCATCATCA'TGGGCACTTTCACCCTGTGCTGGCTGC CCTT
CTTCATCGTTAACATTGTGCATGTGATCCAGGATAACCTCATCCGTAAGGA
AGTTTACATCCTCCTAAATTGGATAGGCTATGTCAATTCTGGTTTCAATCC
CCTTATCTACTGCCGGAGCCCAGATTTCAGGATTC CCTTCCAGGAGCT'TCT'
GTGCCTGCGCAGGTCTTCTTTGAAGGCCTATGGGAATGGCTACTCCAGCA
ACGGCAACACAGGGGAGCAGAGTGGATATCACGTGGAACAGGAGAAAGA
AAATAAACTGCTGTGTGAAGACCTCCCAGGCACGGAAGACTT'TGTGGGCC
ATCAAGGTACTGTGCCTAGCGATAACATTGATTCACAAGGGAGGAATTGT
z\GTACAAATGACTCACTGC.TGTAA
Jl
't
t
,
.l
.!
{
.i
Ij
J
I
,t
I
i
I
I
;
I Amino acid sequence of expressed region: I
IDWMSTIEERVKKIIGEQLGVKQEEVTNNASFVEDLGADSLDTVELVMALEE
EFDTEIPDEEAEKITTVQAAID YINGHQAKLMGQPGNGSAFLLAPNRSHAPDH
DVTQQRDEVWVVGMGIVMSLI VLAIVFGNVLVITAIAKFERLQTVTNYFITSL
ACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVI
AVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTS FLPIQMHWYRATHQE
AINCYANETCCDFFTNQAYAIAS SIV SFWPLVIMVFVYSRVFQEAKRQLQKI
DKSEGRFHVQNL SQVEQDGRTGHGLRRS SKFCL KEHKALKTL GIIMGTFTLC
WLPFFIVNI VHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELL
CLRRS SLKAYGNGYS SNGNTGEQ SGYHVEQEKENKLLCEDLPGTEDFVGHQ
, 
GTVPSDNIDSQGRNCSTNDSLL*
Sequencing results
Antisense primer : pCR3.1-BGHrev
Primer sequence : TAG AAG GCA CAG TCG AGG
Antisense sequence :
CTCTAGACTCGAGCGGCCGCCACTGTGCTGGATATCTTATTAGTGATGGTG
ATGGTGATGGTGATGGTGATGGAATTCCTTATCGTCATCGTC CTTGTAGTC
GGATCCCAGCAGTGAGTCATTTGTACTACAATTCCTCCCTTGTGAATCAAT
GTTATCGCTAGGCACAGTACCTTGATGGCCCACAAAGTCTTCCGTGCCTGG
GAGGTCTTCACACAGCAGTTTATTTTCTTTCTCCTGTTCCACGTGATATC CA
CTCTGCTCCCCTGTGTTGCCGTTGCTGGAGTAGCCATTCCCATAGGCCTTC
A'Iq'AGAAGAC CTGC GCAGGCACAGAAGCTC CTGGAAGGCAATCCTGAAAT
CTGGGCTCC GGCAGTAGATAAGGGGATTG A,/A.ACCAGAATTGACATAGC CT
ATCCAATTTAGGAGGATGTAAACTTCCTTACGGATGAGGTTATCCTGGATC
ACATGCACAATGTTAACGATGAAGAAGGGCAGCCAGCAGAGGGTG A.IA\AG
TGCCCATGATGATGCCTAACGTCTTGAGGGCTTTGTGCTCCTTCAAGCAGA
ACTTGGAAGATCTGCGGAGTCCATGCCCCGTCCGCCCATCCTGCTCCACCT
GGCTAAGGTTCTGGACATGGAAGCGGCCCTCAGATTTGTCAATCTTCTGG
AGCTGCCTTTTGGCCTCCTGAAAGACCCTGGAGTAGACGAAGACCATGAT
CACCAGGGGAACGTAGAAGGACACGATGGAAGAGGCAATGGCATAGGCT
TGGTTCGTGAAGAAGTCACAGCAGGTCTCATTGGCATAGCAGTTGATGGC
TTCCTGGTGGGTGGCCCGGTACCAGTGCATCTGAATGGGCAAGAAGGAGG
TAGGCCTGAC
Sense primer : T7
Primer sequence : (TAA TAC GAC TCA CTA TAG GG)
Sense sequence :
CCCATGCGGCTCTGCATCCCGCAGGTGCTGTTGGCCTTGTTCCTTTCCATG
CTGACAGGGC CGGGAGAAGGCAGC CGGAGGAGGGCCACCCAGATCGATT
ACGTAATGAGCACTATCGAAGAACGCGTTAAGAAAATTATCGGCGAACA
GCTGGGCGTTAAGCAGGAAGAAGTTACCAACAATGCTTCTTTCGTTGAAG
ACCTGGGCGCGGATTCTCTTGACACCGTTGAGCTGGTAATGGCTCTGGAA
GAAGAGTTTGATACTGAGATTCCGGACGAAGAAGCTGAGAAAATCAC CA
CCGTTCAGGCTGCCATTGATTACATCAACGGCCACCAGGCGAAGCTTATG
GGGCAAC CCGGGAACGCCAGCGC CTTCTTGCTGGCACCCAATAGAAGCCA
T'CCGCCGGAC CACGACGTCACGCAGCAAAGGGACGAGGTGTGGGTGGTG
GGCA'| GGGCA'TCC'I'CA'TGTCTCTCATCGTCCTGGC CATCG'TGTTTGGCAAT
GTGCTGGTCATCACAGCCATTGCCAAGTTC GAGCGTCTGCAGACGGTCAC
CAACTACTTCATCACTTCACTGGCCTGTGC TGATCTGGTCATGGGCCTGGC
AGTGGTGCCCTTTGGGGCCGCCCATATTCTTATGAAAATGTGGACTTTTGG
CAACTTCTGGTGCGAGTTTTGGACTTCCATTGATGTGCTGTGCGTCACGGC
CAGCATTGAGACC CTGTGCGTGATCGCAGTGGATCGCTACTTTGCCATTAC
TTCACCTTTCAAGTACCAGAGCCTGCTGACCAAGAATAAGGCC CGGGTGATCATTCTGATGGTGTGGATTGTGTCAGGCCTTACCTCCTTCTTGCCCATTCA
GA'IGCACTGGTACCGGGCCACC CACCAGGAAGCCATCAACTGCTATGCCA
ATGAGACCTGCTGTGACTTCTTCACGAACCAAGCCTATGCCATTGCCTCTT
CCATCGTGTCCTTCTACGTTCCCTGGTGATCATGGTCTTCGTCTACTCCAG
GGTC TTTCAGAGGCAAAAGGCAGCTCAGAAGATT
